|
|
Janet Woodcock
Deputy Commissioner of Operations
Food and Drug Administration
|
|
10:35–11:00 a.m.
|
Questions from the Committee
|
|
11:00–11:45 a.m.
|
Perspectives of Pharmaceutical Manufacturers and Payors
|
|
|
Amit Sachdev
Executive Vice President, Health
Biotechnology Industry Organization (BIO)
|
|
|
Christine Simmon
Vice President of Public Affairs and Development
Generic Pharmaceutical Association (GPhA)
|
|
|
J. Russell Teagarden
Vice President of Clinical Practices & Therapeutics
Medco Health Solutions, Inc. (on behalf of the Pharmaceutical Care Management Association)
|
|
|
Alan Goldhammer
Associate Vice President for Regulatory Affairs
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
|
11:45–12:00 p.m.
|
Questions from the Committee
|
|
12:00–12:45 p.m.
|
Consumer/Patient and Professional Organizations’ Perspectives
|
|
|
David Borenstein
Member, Board of Directors
American College of Rheumatology (ACR)
|
|
|
John A. Gans
Executive Vice-President and Chief Executive Officer
American Pharmacists Association (APhA)
|
|
|
Bill Vaughan
Senior Policy Analyst
Consumers Union
|
|
|
Jeanne Ireland
Director of Public Policy
Elizabeth Glaser Pediatric AIDS Foundation
|